HLA Alloimmunization with Leukocyte Concentrates from HLA-matched and HLA-non-m atched Donors in Patients with H unter s Syndrom e*
|
|
- Henry Lawrence
- 6 years ago
- Views:
Transcription
1 ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 15, No. 5 Copyright 1985, Institute for Clinical Science, Inc. HLA Alloimmunization with Leukocyte Concentrates from HLA-matched and HLA-non-m atched Donors in Patients with H unter s Syndrom e* RAM M. KAKAIYA, M.D.,t ROBERT G REEN STEIN, M.D.,i PATRICIA PISCIOTTO, M.D.,$ SHEILA K. SLOCUM, + DEBBYE ROSEN, R.N.,f RITCHARD G. CABLE, M.D.,f EDWARD E. MORSE, M.D.,$ and AN DREA GAINEY, M.S 4 famerican Red Cross Blood Services Connecticut Region and tdepartment of Pediatrics and Division of Blood Bank and Hematology, Department of Laboratory Medicine, University of Connecticut School of Medicine, Farmington, CT ABSTRACT The incidence and characteristics of HLA alloimmunization following transfusions of leukocyte concentrates as a source of enzyme replacem ent were determ ined in male patients with H unter s syndrome. Five patients were given leukocyte concentrates from HLA m atched donors (Group I) and another five patients received leukocyte concentrates from non-hla m atched donors (Group II). No other blood products were transfused in either group. Im m une response pattern of HLA alloimmunization m easured as the proportion of screening cells manifesting cytotoxicity with patient s sera obtained during th e follow-up period was similar in both groups. HLA alloimmunization is seen with transfused leukocyte concentrates from either HLA-matched or non-hla-matched donors in patients with H unter s syndrome. There appears to be a trend for an earlier onset of HLA alloim m unization w ith few er transfusions w hen leukocyte concentrates from non-hla-m atched donors are transfused as compared to leukocyte concentrates from H LA-m atched donors. O nce HLA alloim m unization occurs, im m une response p a tte rn s appear sim ilar w ith e ith e r leukocyte product. Introduction nom enon has b e e n w ell stu d ie d for A lloim m unization follow ing blood in duction of alloantibodies to re d cell transfusion occurs frequently. This phe- antigens.4 The tim e course of alloimmu- nization to white cell antigens and the * Address reprint requests to: Ram M. Kakaiya, specificities of the antibodies produced M.D., A ssociate D irector, Am erican Red Cross r. l.* i. r 1. i Blood Services, Connecticut Region, 209 Farmington Avenue, Farmington, CT m ultiple transfusions has not been investigated in as m uch detail as is the /85/ $00.90 Institute for Clinical Science, Inc.
2 436 KAKAIYA, GREENSTEIN, PISCIOTTO, SLOCUM, ROSEN, CABLE, MORSE, AND GAINEY case for alloimmunization to red cell antigens. T he use of d iffe re n t transfusion protocols d esig n ed to m odulate the alloim m unization process is increasing.1 Thus, understanding the nature of HLA alloim m unization has therapeutic re le vance to a variety of clinical situations, such as kidney and bone m arrow transplantation, as well as in cell supportive th erap y for hem atologic m alignancies and enzym e re p la c e m e n t th era p y in genetic m etabolic diseases. O ur findings have b e e n previously re p o rte d on th e o ccurrence of HLA alloim m unization in patients receiving transfusions of HLA-m atched leukocyte co n cen trates for enzym e rep lacem en t therapy in patients w ith H u n te r s syndrom e.3 The im m une response was characterized by th e p ro d u ctio n of a w ide variety of HLA alloantibodies including monospecific, duospecific, and m ultispecific HLA an tib o d ies, and antibodies with apparent HLA specificities to the crossreactive antigens of the recipients. In addition to the group of five patients in our previous study, HLA alloim m u nization has been observed in five other patients with H unter s syndrome. These latter patients received leukocyte concentrates collected from random, non- HLA-matched donors. This provided us the opportunity to com pare HLA alloimmunization following transfusions of non- H L A -m atched leukocyte concentrates with our previously reported findings following transfusions of HLA-matched leukocyte concentrates. Serological findings on HLA alloimmunization in these two groups of patients are presented in this report. M aterials and M ethods Lym phocyte HLA typing for th e antigens of HLA-A and B loci was perform ed by the standard N IH microlymphocytotoxicity assay.5 H LA typing was p e r form ed using 58 a n tise ra defining 18 HLA-A locus specificities and 108 antisera defining 37 HLA-B locus specificities. The standard NIH microlymphocytotoxicity te st was also used for HLA alloantibody screening and identification with a panel of 60 screening cells phen o ty p ed for m ost HLA-A and B locus antigens, including the split antigens. A serum sample from each patient was obtained before and periodically th e re after d u rin g transfusion th era p y and stored frozen at 65 C for less than one m onth before testing. E ach serum sam ple was scre e n e d for lym phocytotoxic antibody using a panel of lym phocytes obtained from HLA phenotyped healthy norm al donors. U sually 60 p an el cells w ere u sed for each screening. T he results of those sera m anifesting lym phocytotoxic reactions w ere quantitatively expressed as the percent lymphocytotoxicity calculated by dividing the num ber of panel cells manifesting cytotoxicity by the total num ber of panel cells. The evidence for HLA alloim m unization was defined as the appearance of lymphocytotoxicity observed with a serum sample against at least 15 percent of the panel cells. The tim e at which HLA alloim m unization o ccu rred was calculated in two ways because the periodic screening of the serum for antibody was som ew hat irregular. First, the earliest possible tim e at which alloim m unization could have occurred was based on the absence of antibodies in the latest serum sample. Second, the observed onset of alloim m unization was calculated based on a serum sam ple which showed th e p resence of HLA antibody. An inform ed consent was obtain ed from parents of each study patient before transfusions of leukocyte concentrates were initiated. Leukocyte donors were selected based on a schema described by Duquesnoy et al2 for the first group of p a tie n ts receiving leukocyte co n cen trates from H LA -m atched donors. The
3 ALLOIMMUNIZATION TO LEUKOCYTES 437 degree of H LA -m atching betw een the donor and th e recipient for all transfusions a d m in iste re d to this group I patients has been described in detail in our previous report.3 The second group of patients w ere provided leukocyte conc e n trate s from non-h L A m atched donors. In fact, in th re e of G roup II p a tie n ts, th e HLA p h e n o ty p e of the recip ie n ts was not d e te rm in e d. Both groups of patients received leukocytes from ABO com patible blood donors. Leukocyte concentrates for transfusion to study p a tie n ts w ere p re p a re d as d e scrib ed by us3 previously and contain ed, on average, 6.1 ± 2.2 x 109 (±S D ) leukocytes. The lymphocyte and platelet content of this product was 5.9 ± 2.1 x 109 and 5.5 ± 5.0 x 1010 (mean ± SD), respectively. Statistical analysis was perform ed with a M ann-w hitney U test or a t-test. Results T he characteristics of patients receiving e ith e r HLA m atched (G roup I) or non-hla-m atched (Group II) leukocyte concentrates are shown in table 1. The range and distribution of ages in the two groups were similar. Since the duration of follow-up was less for the Group II as compared to Group I patients, they also received fewer transfusions. The average (±S D ) frequency of all the transfusions was 18.2 ± 25.7 days (N = 214 transfusions) and 21.6 ± 30.3 days (N = 117 transfusions) for G roup I and II patients, respectively. T herefore, transfusion frequency betw een the two groups was similar (p > 0.05). The transfusion frequency was also calculated for transfusions that preceed ed the observed onset of alloim munization and gave an average (±S D ) frequency of 13.4 ± 26.2 days (N = 75 transfusions) and 8.1 ± 12.4 days (N = 33 transfusions) for group I and II p a tie n ts, respectively. This difference was statistically not significant (p > 0.05). As described in the M ethods section, the onset of HLA alloimmunization was calculated in two ways. First, the earliest possible tim e at which alloimmunization could have o ccu rred was calculated TA BLE I C h aracteristics o f P atien ts with Hunter's Syndrome Receiving HLA-matched (Group I) or Non-HLA Matched Leukocytes (Group II) A ge ( y r s ) D u r a t i o n o f F o l l o w - u p (mo) E a r l i e s t P o s s i b l e A llo im m u n i z a t i o n (mo) O b s e r v e d O n s e t o f A llo im m u n i z a t i o n (m o) T r a n s f u s i o n s B e f o r e O b s e r v e d O n s e t o f A llo im m u n i- z a t i on T o t a l T r a n s f u s i o n s G ro u p I G ro u p I I NK* M ean ± SD 11,.4 ± ± ± ± ± NK 5. 0 ( d a y s ) NK M ean ± SD 8..1 ± ± ± ± ± 'NK = N o t know n
4 438 KAKAIYA, GREENSTEIN, PISCIOTTO, SLOCUM, ROSEN, CABLE, MORSE, AND GAINEY based on the absence of antibodies in the latest seru m sam ple. Second, th e observed onset of alloim m unization was calculated based on a serum sample which showed the presence of HLA antibody. It should be n o ted th at th e alloim unization could have o ccu rred b e tw een th e tim e at w hich one seru m sample was negative and the following one which showed the presence of HLA antibodies. This tim e lag for group I patients, namely, patients #1, #2, #3, and # 5, was si?^ one, zero, and eight m onths, respectively. F or p a tie n t # 4, the first post-transfusion sample obtained at four m onths was positive and, th e re fore, this tim e lag could not b e calculated. The tim e lag for group II patients, namely, patients #6, #8, and #9, was 0.5, one, and two months, respectively. For patients # 7 and #10, the first followup sample obtained at five days and four months, respectively, was positive and, therefore, this tim e log could not be calculated. As shown in table I, for G roup II patients, th e observed onset of alloimm unization was som ew hat earlie r and with fewer transfusions as com pared to th e G roup I p a tie n ts, p = and 0.028, respectively. All patients becam e alloim m unized. The im m une response pattern for each patient was m easured as the proportion of p anel cells m anifesting cytotoxicity with a given serum sample. As seen in figures 1 and 2, once th e im m une response was generated, it was generally well sustained in each patient. Only one patient, namely, patient #8, appeared to be a low responder as judged by a low percent reactivity with the patient s sera obtain ed at d ifferen t intervals. This patient also received the least num ber of transfusions and was follow ed for the shortest interval (seven months). Except for this p a tie n t, th e resp o n se p a tte rn ap p eared sim ilar am ong all o th e r p a tients. Months Months Months F i g u r e 1. Patients # 1 to 5 received leukocytes from HLA-matched donors. Percent cytotoxicity is the percentage of screening cells manifesting cytotoxicity with patient s serum.
5 ALLOIMMUNIZATION TO LEUKOCYTES 439 Patient #6 Patient #7 Patient * Months Months Months F i g u r e 2. Patients #6 to 10 received leukocytes from non-hla-matched donors. Percent cytotoxicity is the percentage of screening cells manifesting cytotoxicity with patient s serum. Discussion The findings dem onstrate the occurrence of HLA alloimmunization to transfusions of non-hla-m atched leukocyte concentrates in patients w ith H u n te r s syndrom e. This is c o n sisten t w ith our previous observations in w hich HLAalloimmunization was seen in a group of patients transfused with HLA-matched leukocyte concentrate.3 Donor-recipient HLA incompatibilities w ere not known for the group of patients who received non-h L A -m atched leukocyte co n cen trates. In contrast, the donor-recipient HLA in com patibilities w ere clearly d efin ed in p a tien ts receiv in g HLAm atched leukocyte concentrates. In fact, in these latter patients, as per our p revious re p o rt, p e rc e n t of HLA-A locus and 21.7 percent of HLA-B locus donor antigens w ere incom patible with th e re c ip ie n t s HLA antigens. E ven then, a trend towards an earlier onset of HLA alloimmunization with fewer transfusions was noticed with the non-hlam atched leukocyte concentrates as com p a red to th e H L A -m atched leukocyte concentrates. This trend was not due to a difference in th e age or in th e fre quency of transfusion betw een the two groups of p atien ts. E ventually, all patients developed HLA alloim m unization regardless of the type of leukocyte p ro d u ct. O nce alloim m unization was detected, the im m une response pattern that followed was similar in both groups and was ch aracterized by a co n sisten t high percent lym phocytotoxicity found with the patient s sera during follow-up period. It should be noted that the num ber of patients with H unter s syndrom e studied by us is small. Also, m ost of our patients were children. Thus, the implications of our findings to other situations in which
6 440 KAKAIYA, GREENSTEIN, PISCIOTTO, SLOCUM, ROSEN, CABLE, MORSE, AND GAINEY HLA alloim m unization occurs should co n sid er th e lim itations m en tio n ed in our study. T he d ata suggest th at th e im m une resp o n se p a tte rn is sim ilar, once it occurs, regardless of w h e th e r HLAm atched or non-hla-m atched leukocyte co n cen trates are transfused. T h ere appears to be a trend towards an earlier o n set of HLA alloim m unization w ith few er transfusions w ith non-h L A - m atched as compared to HLA-matched leukocyte concentrates. References 1. B r e n t, L., F a b r e, J. W., E l v e s, M. W., and S e l l s, R. A.: Proceedings of the Ninth International Congress of the Transplantation Society. The blood transfusion effect in man and in experimental animals. Transplant. Proc. i5 : , D u q u e s n o y, R. J., F i l i p, D. J., R o d e y, G. E., R i m m, A. A., and A s t e r, R. H. : Successful transfusion of platelets mismatched for HLA antigens to alloim m un ized th rom b ocytopen ic patients. Am. J. Hematol. 2: , K a k a iy a, R. M., G r e e n s t e i n, R., P i s c i o t t o, P., S l o c u m, S., R o s e n, D., C a b l e, R. G., and M o r s e, E. E.: Characteristics and natural history o f alloim m unization fo llo w in g HLAmatched leukocyte transfusions. Ann. Clin. Lab. Sci. 14: , M o l l i s o n, P. L.: Blood Transfusion in Clinical M edicine, 7th ed. Oxford, Blackwell Scientific Publications, S t a f f : Transplantation and Immunology Branch ( ). NIH lymphocyte microcytotoxicity tech nique. N IA ID M anual o f T issue Typing Techniques; Ray, J. G., ed. NIH Pub. No , pp , 1980.
Clinical Trial of Young Red Blood Cells Prepared by Apheresis
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 16, No. 6 Copyright 1986, Institute for Clinical Science, Inc. Clinical Trial of Young Red Blood Cells Prepared by Apheresis PATRICIA PISCIOTTO, M.D.,* THOMAS
More informationSensitivity of Serum Fructosamine in Short Term Glycemic Control
A N N A L S O F C L IN IC A L A N D L A B O R A T O R Y S C IE N C E, Vol. 19, N o. 2 Copyright 1989, Institute for Clinical Science, Inc. Sensitivity of Serum Fructosamine in Short Term Glycemic Control
More informationReemergence of the International Normalized Ratio for the Standardization of Prothrombin Time*
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 23, No. 3 Copyright 1993, Institute for Clinical Science, Inc. Reemergence of the International Normalized Ratio for the Standardization of Prothrombin
More informationEffects of Alcohol on Visual, Cognitive & Motor Performances Related to a Complex Manual Control Task
Effects of Alcohol on Visual, Cognitive & Motor Performances Related to a Complex Manual Control Task R obert S. K ennedy*, Janet J. Turnage*, D eborah L. H arm ** and Julie M. Drexler*** *Essex Corporation,
More informationThyroid Screening in the Newborn: Utah Experience
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 13, No. 1 Copyright 1983, Institute for Clinical Science, Inc. Thyroid Screening in the Newborn: Utah Experience BRUCE A. BUEHLER. M.D.,* MELVIN J. GORTATOUSKI,
More informationE levated Prolactin Level in Prostates with Latent Carcinoma
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 17, No. 3 Copyright 1987, Institute for Clinical Science, Inc. E levated Prolactin Level in Prostates with Latent Carcinoma RYUICHI YATANI, M.D.,* ITSUO
More informationLONG DIALYSIS SESSIONS (DAILY, NOCTURNAL ETC) Ercan Ok, Izm ir, Turkey. Chair: Mustafa Arici, Ankara, Turkey Bernard Canaud, Montpellier, France
LONG DIALYSIS SESSIONS (DAILY, NOCTURNAL ETC) Ercan Ok, Izm ir, Turkey Chair: Mustafa Arici, Ankara, Turkey Bernard Canaud, Montpellier, France Prof Ercan Ok Divis ion of N ephrology E ge U nivers ity
More informationResponse of Red Blood Cell Control Materials to Altered Testing Conditions
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 18, No. 1 Copyright 1988, Institute for Clinical Science, Inc. Response of Red Blood Cell Control Materials to Altered Testing Conditions MARK E. SHERMAN,
More informationAssociation of Renal Graft Survival with Matching at the HLA-DR Locus
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 14, No. 6 Copyright 1984, Institute for Clinical Science, Inc. Association of Renal Graft Survival with Matching at the HLA-DR Locus KARLA J. LAUENSTEIN,
More informationAssessment of Cellular Immune Response to Cancer of the Breast
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 9, No. 6 Copyright 1979, Institute for Clinical Science, Inc. Assessment of Cellular Immune Response to Cancer of the Breast RONALD B. HERBERM AN, M.D. Laboratory
More informationProblems with Outliers in Breath Alcohol Testing
Problems with Outliers in Breath Alcohol Testing Jo c h e n W ilske Blood alcohol concentration (BAC) and impairment o f driving skills are related so closely, that statutory drink-drive limits are accepted
More informationPlatelet Satellitosis: A Case Report with Laboratory Characterization and Quantitative Evaluation*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 9, No. 2 Copyright 1979, Institute for Clinical Science, Inc. Platelet Satellitosis: A Case Report with Laboratory Characterization and Quantitative Evaluation*
More informationCurrent Status of Leukocyte and Platelet Administration in Cancer Therapy
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 13, No. 6 Copyright 1983, Institute for Clinical Science, Inc. Current Status of Leukocyte and Platelet Administration in Cancer Therapy ERNEST M. WALKER
More informationA Comparison of two Macroscopic Platelet Agglutination Assays for von Willebrand Factor
ANNALS O F CLINICAL AND LABORATORY SC IEN CE, Vol. 20, No. 1 Copyright 1990, Institute for Clinical Science, Inc. A Comparison of two Macroscopic Platelet Agglutination Assays for von Willebrand Factor
More informationAnalysis of Two Types of Granulocyte Transfusions in Patients with Acute Leukemia and Septicemia
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 12, No. 2 Copyright 1982, Institute for Clinical Science, Inc. Analysis of Two Types of Granulocyte Transfusions in Patients with Acute Leukemia and Septicemia
More informationControlled-Release Carbidopa-Levodopa (Sinemet) in Combination with Standard Sinemet in Advanced Parkinson s Disease
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 19, No. 2 Copyright 1989, Institute for Clinical Science, Inc. Controlled-Release Carbidopa-Levodopa (Sinemet) in Combination with Standard Sinemet in
More informationAntithymocyte Serum Suppression of Immunity in Mice Immunized to Leishmania donovani*
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 20, No. 4 Copyright 1990, Institute for Clinical Science, Inc. Antithymocyte Serum Suppression of Immunity in Mice Immunized to Leishmania donovani* G.
More informationErythrocyte Uroporphyrinogen I Synthase Activity as an Indicator of Acute Porphyria
A N N A L S O F C L IN IC A L A N D L A B O R A T O R Y S C IE N C E, Vol. 19, N o. 2 Copyright 1989, Institute for Clinical Science, Inc. Erythrocyte Uroporphyrinogen I Synthase Activity as an Indicator
More informationThe Effectiveness of ASAP Education and Rehabilitation Programs
The Effectiveness of ASAP Education and Rehabilitation Programs James L. Nichols 1 EDUCATIONAL PROGRAMS B ackground and D escription Educational programs for convicted drinking drivers have recently received
More informationAn Approach to the Patient Refractory to Platelets Transfusion. Harold Alvarez, MD
Harold Alvarez, MD Objectives Explain the etiology of platelet refractoriness Discuss the different types of platelet refractoriness Describe how platelet refractoriness is diagnosed Discuss different
More informationPathological Evaluation of WR Administered Orally in Irradiated and Non-Irradiated Male Mice
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 22, No. 3 Copyright > 1992, Institute for Clinical Science, Inc. Pathological Evaluation of WR-151327 Administered Orally in Irradiated and Non-Irradiated
More informationViscoelastic Measurement of Clot Formation: A New Test of Platelet Function
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 13, No. 2 Copyright 1983, Institute for Clinical Science, Inc. Viscoelastic Measurement of Clot Formation: A New Test of Platelet Function ABDUS SALEEM,
More informationOPTN/UNOS Policy Notice Review of HLA Tables (2016)
Review of HLA Tables (2016) Sponsoring Committee: Policy/Bylaws Affected: Histocompatibility Policy 4.10 (Reference Tables of HLA Antigen Values and Split Equivalences) Public Comment: July 31, 2017 October
More informationEvaluation of Two New Antibody Detection Techniques in Kidney Transplantation. Doctoral Thesis. Dr. Petra Gombos
Evaluation of Two New Antibody Detection Techniques in Kidney Transplantation Doctoral Thesis Dr. Petra Gombos Semmelweis University Doctoral School of Pathology Supervisor: Dr. Róbert Langer, Ph.D. Consultant:
More informationWhole Blood Viscosity in Beta Thalassemia Minor
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 22, No. 4 Copyright 1992, Institute for Clinical Science, Inc. Whole Blood Viscosity in Beta Thalassemia Minor JAMES P. CROWLEY, M.D.t, JACLYN B. M ETZGER,
More informationPrevalence o f M -proteins in Serum o f H ospitalized Patients
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 17, No. 3 Copyright 1987, Institute for Clinical Science, Inc. Prevalence o f M -proteins in Serum o f H ospitalized Patients Physicians Response to Finding
More informationCA-549: Immunohistochemistry and Serum Levels in Breast Carcinoma and Other Neoplasms*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 19, No. 6 Copyright 1989, Institute for Clinical Science, Inc. CA-549: Immunohistochemistry and Serum Levels in Breast Carcinoma and Other Neoplasms* MUHAMMAD
More informationU se o f Cerebrospinal Fluid Lactic Acid Concentration in the Diagnosis of Fungal M eningitis
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 17, No. 6 Copyright 1987, Institute for Clinical Science, Inc. U se o f Cerebrospinal Fluid Lactic Acid Concentration in the Diagnosis of Fungal M eningitis
More information25/10/2017. Clinical Relevance of the HLA System in Blood Transfusion. Outline of talk. Major Histocompatibility Complex
Clinical Relevance of the HLA System in Blood Transfusion Dr Colin J Brown PhD FRCPath. October 2017 Outline of talk HLA genes, structure and function HLA and immune complications of transfusion TA-GVHD
More informationScreening Hospitalized Injured Drivers and Other Trauma Victims for Alcoholism Using Two Questions
Screening Hospitalized Injured Drivers and Other Trauma Victims for Alcoholism Using Two Questions C arl A. S o d e r str o m, M.D.,1 P a tricia C. D isc h in g e r, P h.d.,2 G ord on S. S m ith, M.D.3
More informationGuidelines for the Management of Platelet Transfusion Refractoriness GUIDELINES FOR THE MANAGEMENT OF PLATELET TRANSFUSION REFRACTORINESS
GUIDELINES FOR THE MANAGEMENT OF PLATELET TRANSFUSION REFRACTORINESS Reviewed by Dr Colin Brown (26/03/2008) Author(s): Colin Brown Page 1 of 7 Purposes To define and recommend policies and procedures
More informationThe Use of HLA /HPA Selected Platelets
The Use of HLA /HPA Selected Platelets Dr Colin Brown PhD FRCPath. Consultant Clinical Scientist Histocompatibility and Immunogenetics HLA and Transfusion Human Leucocyte Antigens HLA Human Platelet Antigens
More informationBasel - 6 September J.-M. Tiercy National Reference Laboratory for Histocompatibility (LNRH) University Hospital Geneva
Basel - 6 eptember 2012 J.-M. Tiercy National Reference Laboratory for Histocompatibility (LNRH) University Hospital Geneva Outline the HLA system is (a) complex anti-hla immunisation and alloreactivity
More informationHLA Selected Platelets
HLA Selected Platelets Dr PhD Clinical Scientist Department of Histocompatibility & Immunogenetics NHS Blood and Transplant Colindale Poor increment (
More informationNeutrophil Antigens and Antibodies in the Diagnosis of Immune Neutropenias *f
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 19, No. 3 Copyright 1989, Institute for Clinical Science, Inc. Neutrophil Antigens and Antibodies in the Diagnosis of Immune Neutropenias *f PR EM A R.
More informationAn Assay for Monitoring Response to Therapy in Cancer Patients*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 23, No. 3 Copyright 1993, Institute for Clinical Science, Inc. An Assay for Monitoring Response to Therapy in Cancer Patients* CALVIN C. W ILH ID E, P h.d.tt
More informationImmunological Techniques to Differentiate Lymphoma from other Malignancies*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 22, No. 5 Copyright 1992, Institute for Clinical Science, Inc. Immunological Techniques to Differentiate Lymphoma from other Malignancies* EDWARD E. MORSE,
More informationEFFEC TS O F N O ISE O N C O G N ITIV E PROCESSES O F IN D IV ID U A L S IN A LABORATORY E X PERIM ENT
Polish Journal of Occupational Medicine and Environmental Health Vol. 4, N o 3, 269-279, 1991 EFFEC TS O F N O ISE O N C O G N ITIV E PROCESSES O F IN D IV ID U A L S IN A LABORATORY E X PERIM ENT BO H
More informationUrinary Lactate Dehydrogenase Isoenzym e Analysis in Adult Population*
ANNALS O F CLINICAL A N D LABORATORY SC IE N C E, Vol. 15, No. 1 Copyright 1985, Institute for Clinical Science, Inc. Urinary Lactate Dehydrogenase Isoenzym e Analysis in Adult Population* TSIEH SUN, M.D.,t
More informationBlood Component Testing and Labeling
Blood Component Testing and Labeling Each donor unite must be tested and properly labeled before its release for transfusion. Required Tests: In most blood banks, pretransfusion testing involves determining
More informationFor broad-split groups where the broad antigen was very rare, we excluded the broad antigen and analyzed each child antigen as their own category.
Description of categorization of broad and split antigens HLA antigen classifications have evolved over time as assay development has allowed the detection of differences in antigens ( split categories)
More informationOrgan transplantation in Bulgaria
Cell Tissue Banking (28) 9:337 342 DOI 1.17/s1561-7-935-2 Organ transplantation in Bulgaria Elissaveta Naumova Æ Petar Panchev Æ Pencho J. Simeonov Æ Anastassia Mihaylova Æ Kalina Penkova Æ Petia Boneva
More informationH yperglycem ic M acrocytosis in Electronically D eterm ined M ean Corpuscular Volume
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 15, No. 4 Copyright 1985, Institute for Clinical Science, Inc. H yperglycem ic M acrocytosis in Electronically D eterm ined M ean Corpuscular Volume Use
More informationClinical Relevance of the HLA System in Blood Transfusion. Dr Colin J Brown PhD FRCPath. October 2017
Clinical Relevance of the HLA System in Blood Transfusion Dr Colin J Brown PhD FRCPath. October 2017 Outline of talk HLA genes, structure and function HLA and immune complications of transfusion TA-GVHD
More informationManagement of platelet refractory patients, why does your patient keep on bleeding? Dr Colin Brown, H&I Dept, NHSBT Colindale
Management of platelet refractory patients, why does your patient keep on bleeding? Dr Colin Brown, H&I Dept, NHSBT Colindale Pooled Platelets (Buffy Coat Derived) Adult dose from 4 ABO-identical donors
More informationNodular Regenerative Hyperplasia of the Liver with and without Portal Hypertension: A Comparison
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 16, No. 2 Copyright 1986, Institute for Clinical Science, Inc. Nodular Regenerative Hyperplasia of the Liver with and without Portal Hypertension: A Comparison
More informationIndian Journal of Nephrology Indian J Nephrol 2001;11: 88-97
88 Indian Journal of Nephrology Indian J Nephrol 2001;11: 88-97 ARTICLE HLA gene and haplotype frequency in renal transplant recipients and donors of Uttar Pradesh (North India) S Agrawal, AK Singh, RK
More informationEctopic Hormone Production by Malignant Tumors
ANNALS O F CLINICAL AND LABORATORY SCIENCE, Vol. 9, No. 4 Copyright 1979, Institute for Clinical Science, Inc. Ectopic Hormone Production by Malignant Tumors IRW IN J. H O LLA N D ER, M.D. and GONZALO
More informationCOMMENTARY Oncogenes: An Overview
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 13, No. 2 Copyright 1983, Institute for Clinical Science, Inc. COMMENTARY Oncogenes: An Overview DANIEL LEIGH WEISS, M.D. National Research Council, Washington,
More informationAssessment of Results of Estrogen and Progesterone Receptor Assays Performed in a Community Hospital
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 16, No. 4 Copyright 1986, Institute for Clinical Science, Inc. Assessment of Results of Estrogen and Progesterone Receptor Assays Performed in a Community
More informationP rocessing In structions and the G eneration E ffect: A T est of the M ultifactor T ransfer-appropriate P rocessing T heory
Ó M E M O R Y, 1 99 7, 5 (3 ), 4 01 ±42 1 P rocessing In structions and the G eneration E ffect: A T est of the M ultifactor T ransfer-appropriate P rocessing T heory Patricia A. dew instanle y O berlin
More informationInstitut für Biologie II, Lehrstuhl für G enetik, U niversität Tübingen, A uf der M orgenstelle 28, D-7400 Tübingen
Relationship between Flower Development, Anthocyanin Accumulation and Activity o f Enzymes Involved in Flavonoid Biosynthesis in Matthiola incana R. Br. B. D angelm ayr, G. Stotz, R. Spribille, and G.
More informationWHAT IS EARLY START AND WHY IT SHOULD NOT BE SYSTEMATIC? Christian Com be, Bordeaux, France
WHAT IS EARLY START AND WHY IT SHOULD NOT BE SYSTEMATIC? Christian Com be, Bordeaux, France Chair: Mustafa Arici, Ankara, Turkey Bernard Canaud, Montpellier, France Prof Christian Combe Servic e de N éphrologie
More informationRapid Enzymatic Determination of Amylase in Serum and Urine Using a Centrifugal Analyzer*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 9, No. 5 Copyright 1979, Institute for Clinical Science, Inc. Rapid Enzymatic Determination of Amylase in Serum and Urine Using a Centrifugal Analyzer* STEVEN
More informationA Supplement to Alkaline Phosphatase Fractionations: Utilization of Gamma- Glutamyl Transpeptidase and Hydroxyproline Assays
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 8, No. 2 Copyright 1978, Institute for Clinical Science A Supplement to Alkaline Phosphatase Fractionations: Utilization of Gamma- Glutamyl Transpeptidase
More informationThe Effect of Vitamins C and E on Lipid Peroxidation in Stored Erythrocytes*
ANNALS O F CLINICAL AND LABORATORY SCIENCE, Vol. 23, No. 1 Copyright 1993, Institute for Clinica! Science, Inc. The Effect of Vitamins C and E on Lipid Peroxidation in Stored Erythrocytes* JOSEPH A. KNIGHT,
More informationHong Kong Journal Nephrol of 2000;(2): Nephrology 2000;2(2): BR HAWKINS ORIGINAL A R T I C L E A point score system for allocating cadaver
Hong Kong Journal Nephrol of 2000;(2):79-83. Nephrology 2000;2(2):79-83. ORIGINAL A R T I C L E A point score system for allocating cadaveric kidneys for transplantation based on patient age, waiting time
More informationUpdate to the Human Leukocyte Antigens (HLA) Equivalency Tables
Update to the Human Leukocyte s (HLA) Equivalency Tables Sponsoring Committee: Histocompatibility Policy/Bylaws Affected: Policy 2.11.A: Required Information for Deceased Kidney Donors, Policy 2.11.B:
More informationLight Microscopical Examination of Glomerular Basement Membrane in Systemic Lupus Erythematosus
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 8, No. 1 Copyright 1978, Institute for Clinical Science Light Microscopical Examination of Glomerular Basement Membrane in Systemic Lupus Erythematosus J.
More informationHemoglobin Alc and Diabetes Mellitus
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 10, No. 2 Copyright 1980, Institute for Clinical Science, Inc. Hemoglobin Alc and Diabetes Mellitus HYMAN ROCHM AN, P h.d., M.D. Department o f Pathology,
More informationHemoglobin Variant Detection from Dried Blood Specimens by High Performance Liquid Chromatography*!
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 23, No. 6 Copyright 1993, Institute for Clinical Science, Inc. Hemoglobin Variant Detection from Dried Blood Specimens by High Performance Liquid Chromatography*!
More information10/18/2012. A primer in HLA: The who, what, how and why. What?
A primer in HLA: The who, what, how and why What? 1 First recognized in mice during 1930 s and 1940 s. Mouse (murine) experiments with tumors Independent observations were made in humans with leukoagglutinating
More informationAcquired von Willebrand s Disease Following Bone Marrow Transplantation*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 24, No. 3 Copyright 1994, Institute for Clinical Science, Inc. Acquired von Willebrand s Disease Following Bone Marrow Transplantation* JOHN LAZARCHICK,
More informationChapter 10. Histocompatibility Testing
Chapter 10 Histocompatibility Testing Change record Date Author Version Change reference 08-03-2013 J. de Boer 2.0 Textual Adjustments 13-09-2012 C.M. Tieken 1.1 Text added page 2 10-03-2012 I. Doxiadis
More informationChapter 10. Histocompatibility Testing
Chapter 10 Histocompatibility Testing Chapter 10 Histocompatibility Testing Table of Contents 10.1 General... 3 10.1.1 Registration of renal transplant patients...3 10.1.2 Material for histocompatibility
More informationAntibody identification. Antibody specificity
Red blood cell (RBC) transfusions are frequently used in sickle-cell anaemia (SCA) patients to treat and prevent the complications of their disease. Acute simple transfusions are usually used to treat
More informationPeroperative Pancreatic Aspirations
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 9, No. 1 Copyright 1979, Institute for Clinical Science, Inc. Peroperative Pancreatic Aspirations ROBERTA K. NIEBERG, M.D. Department of Pathology, Harbor
More informationSerum Calcitonin in Thyroid Disorders and in Pheochromocytoma Kindred*
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 16, No. 2 Copyright 1986, Institute for Clinical Science, Inc. Serum Calcitonin in Thyroid Disorders in Pheochromocytoma Kindred* F. J. H ORNICEK, P H.D.,t$
More informationThe MHC and Transplantation Brendan Clark. Transplant Immunology, St James s University Hospital, Leeds, UK
The MHC and Transplantation Brendan Clark Transplant Immunology, St James s University Hospital, Leeds, UK Blood Groups Immunofluorescent staining has revealed blood group substance in the cell membranes
More informationAutism Spectrum Disorders (ASD)
Autism Spectrum Disorders (ASD) Pervasive brain developmental disorders causing severe impairment in thinking, feeling, communication, eye contact and ability to relate to others, repetitive behavior Seen
More informationImmunohematology Case Studies
Immunohematology Case Studies 2016-2 Nicole Thornton International Blood Group Reference Laboratory (IBGRL) NHS Blood and Transplant Bristol, United Kingdom nicole.thornton@nhsbt.nhs.uk Clinical History
More informationInsulin or Insulin-like Peptides in the Hum an Pituitary*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 17, No. 2 Copyright 1987, Institute for Clinical Science, Inc. Insulin or Insulin-like Peptides in the Hum an Pituitary* G. CO LIN BUDD, P H.D.,n BEN PANSKY,
More informationUse of Terminal Deoxynucleotidyl Transferase in the Diagnosis of Leukemia
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 13, No. 2 Copyright 1983, Institute for Clinical Science, Inc. Use of Terminal Deoxynucleotidyl Transferase in the Diagnosis of Leukemia EDWARD E. MORSE,
More informationSTUDIES OF R H E U M A T IC D IS E A S E 1. Ross L. G a u l d a n d F r a n c e s E. M. R ea d 2
STUDIES OF R H E U M A T IC D IS E A S E 1 I I I. F A M I L I A L A S S O C IA T IO N A N D A G G R E G A T IO N I N R H E U M A T I C D IS E A S E Ross L. G a u l d a n d F r a n c e s E. M. R ea d 2
More informationVirtual Crossmatch in Kidney Transplantation
Virtual Crossmatch in Kidney Transplantation Shiva Samavat Associate Professor of Nephrology Labbafinejad Hospital SBMU 2018.11.21 All transplant candidates are screened to determine the degree of humoral
More informationAcquired Coagulopathy Owing to Parenteral Cefamandole: Renal Failure as a Predisposing Factor*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 13, No. 5 Copyright 1983, Institute for Clinical Science, Inc. Acquired Coagulopathy Owing to Parenteral Cefamandole: Renal Failure as a Predisposing Factor*
More informationSmoking and Health Dr Saqib Shahab Medical Health Officer
Smoking and Health Dr Saqib Shahab Medical Health Officer 1 YORKTON SMOKE FREE PUBLIC PLACES COMMITTEE PUBLIC OPINION SURVEY SEPTEMBER 2003 2 Second-hand smoke carries health risks to nonsmokers. 80% 70%
More informationTransfusion Practices and Creation of a Registry for Patients with Sickle Cell Disease within the Atlanta Sickle Cell Consortium
Transfusion Practices and Creation of a Registry for Patients with Sickle Cell Disease within the Atlanta Sickle Cell Consortium Annie Winkler MD Assistant Professor, Emory University Department of Pathology
More informationXIV. HLA AND TRANSPLANTATION MEDICINE
XIV. HLA AND TRANSPLANTATION MEDICINE A. Introduction 1. The HLA system includes a complex array of genes and their molecular products that are involved in immune regulation and cellular differentiation.
More informationHLA ANTIGEN FREQUENCY OF NORTHERN IRELAND BLOOD DONORS
HLA ANTIGEN FREQUENCY OF NORTHERN IRELAND BLOOD DONORS by D. MIDDLETON Transplantation and Clinical Immunology, Belfast City Hospital J. MARTIN * Transplantation and Clinical Immunology, Belfast City Hospital
More informationThe Effect of Varying Weightload Intensities on Biceps Curl Technique
Western Michigan University ScholarWorks at WMU Master's Theses Graduate College 12-1992 The Effect of Varying Weightload Intensities on Biceps Curl Technique Jeffrey C. Gailhouse Western Michigan University
More informationAlterations in von Willebrand Factor Antigen in Premature Infants with Respiratory Distress Syndrome and Chronic Lung Disease*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 23, No. 1 Copyright 1993, Institute for Clinical Science, Inc. Alterations in von Willebrand Factor Antigen in Premature Infants with Respiratory Distress
More informationLong-Term Efficacy of Controlled-Release Carbidopa/Levodopa in Patients with Advanced Parkinson s Disease*
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 19, 6 Copyright 1989, Institute for Clinical Science, Inc. Long-Term Efficacy of Controlled-Release Carbidopa/Levodopa in Patients with Advanced Parkinson
More informationABO Hemolytic Disease of the Newborn
ABO Hemolytic Disease of the Newborn A Retrospective Analysis of 5 Cases D. ROBERT DUOUR,.D. AND W. PATRICK ONOGHAN, PH.D. Dufour, D. Robert and onaghan, W. Patrick: ABO hemolytic disease of the newborn.
More informationHuman leukocyte antigen (HLA) matching has a beneficial
IMMUNOBIOLOGY AND GENOMICS Predicting the Immunogenicity of Human Leukocyte Antigen Class I Alloantigens Using Structural Epitope Analysis Determined by HLAMatchmaker Vasilis Kosmoliaptsis, 1,2 J. Andrew
More informationShould red cells be matched for transfusions to patients listed for renal transplantation?
Should red cells be matched for transfusions to patients listed for renal transplantation? Dr M.Willicombe Imperial College Renal and Transplant Centre, Hammersmith Hospital Should red cells be matched
More informationPILOT STUDY OF ANTIGEN MATCHING FOR AUTOIMMUNE HEMOLYTIC ANEMIA
PILOT STUDY OF ANTIGEN MATCHING FOR AUTOIMMUNE HEMOLYTIC ANEMIA Sharon Rice & Fred Plapp Saint Luke s Hospital Kansas City, MO CENTRALIZED TRANSFUSION SERVICE Antibody identification Antibody titer Antigen
More informationInvolvement of Hormones in the Swift Increase in Alcohol Metabolism*f
ANNALS O F C L IN IC A L A N D LABORATORY S C IE N C E, Vol. 18, No. 4 Copyright 1988, Institute for Clinical Science, Inc. Involvement of Hormones in the Swift Increase in Alcohol Metabolism*f DONALD
More informationEvaluation of Three Methods of Protein Analysis for Serum and Heart Homogenates
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 9, No. 2 Copyright 1979, Institute for Clinical Science, Inc. Evaluation of Three Methods of Protein Analysis for Serum and Heart Homogenates JON ATH AN
More informationM onitoring of Drugs in Breast Milk
ANNALS O F CLIN IC A L A N D LABORATORY SC IE N C E, Vol. 15, No. 2 Copyright 1985, Institute for Clinical Science, Inc. M onitoring of Drugs in Breast Milk STEVEN H. Y. W ONG, P h.d. Department of Laboratory
More information8/28/2018. Disclosures. Objectives. None. Automation to PreciseType and Everything in Between
Automation to PreciseType and Everything in Between Jessie Singer MT(ASCP) Transfusion Medicine Children s Hospital Los Angeles None Disclosures Objectives Describe the application of molecular testing
More informationAutomation to PreciseType and Everything in Between. Jessie Singer MT(ASCP) Transfusion Medicine Children s Hospital Los Angeles
Automation to PreciseType and Everything in Between Jessie Singer MT(ASCP) Transfusion Medicine Children s Hospital Los Angeles None Disclosures Objectives Describe the application of molecular testing
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTRY INFORMTION doi:10.1038/nature11808 NT Phen Met ICR Oligo FCCP pmpk tmpk Supplemental figure 1. -. Primary hepatocytes were treated with 250 um Phenformin, 1 mm Metformin 250 um ICR, 100 nm
More informationProblems in the Diagnosis of Transferase and Galactokinase D eficient Galactosemia
AN NALS O F CLINICA L A N D LABORATORY SC IENCE, Vol. 10, No. 1 Copyright 1979, Institute for Clinical Science, Inc. Problems in the Diagnosis of Transferase and Galactokinase D eficient Galactosemia M
More informationIt s not just allo-antibodies that a red cell transfusion can stimulate
It s not just allo-antibodies that a red cell transfusion can stimulate Associate Professor Ralph Green Laboratory Medicine RMIT University Melbourne, Australia Transfusion practice Minimise risk of transmitting
More informationElevation of Creatine Kinase BB CK in Hospitalized Patients
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 12, No. 5 Copyright 182, Institute for Clinical Science, Inc. Elevation of Creatine Kinase BB CK in Hospitalized Patients Importance of Distinguishing BB
More informationResistance Against Leishmania donovani Induced with an Aluminum Hydroxide Vaccine
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 18, No. 2 Copyright 1988, Institute for Clinical Science, Inc. Resistance Against Leishmania donovani Induced with an Aluminum Hydroxide Vaccine J. C. JARECKI-BLACK,*
More information- Transplantation: removing an organ from donor and gives it to a recipient. - Graft: transplanted organ.
Immunology Lecture num. (21) Transplantation - Transplantation: removing an organ from donor and gives it to a recipient. - Graft: transplanted organ. Types of Graft (4 types): Auto Graft - From a person
More informationHEADACHES AFTER Bone Marrow Transplant
HEADACHES AFTER Bone Marrow Transplant This is the first slide Peter Russell, Supervising Scientist, Transfusion Haematology, Queensland Pathology Central RBWH, Herston Rd, HERSTON, QLD. 4029, Australia.
More informationProinsulin Level in Diabetes Mellitus Measured by a New Immunochemiluminometric Assay*
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 25, No. 6 Copyright 1995, Institute for Clinical Science, Inc. Proinsulin Level in Diabetes Mellitus Measured by a New Immunochemiluminometric Assay* TA-JEN
More information